Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr has removed all 17 members of the CDC's Advisory Committee on ...

AbbVie presented new data from its novel antibody-drug conjugates (ADCs) at ASCO 2025, including telisotuzumab adizutecan ...

Going into 2025, we expect pharma brands and their advertising partners to use past learnings – and, more importantly – ...

Changing a cultural undertow is one of the hardest leadership challenges in any industry, and perhaps even more so in the ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

The NHS is reported to be in line for a £30 billion ($40.7 billion) increase to its budget in the UK government's upcoming ...

Clesrovimab has been held up by MSD (known as Merck & Co in the US and Canada) as offering simpler dosing and better clinical ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

It is the first fundraising effort at Neuralink since its $280 million Series D round in 2023 and brings the company's total ...